Covered recipient · General Payments record
ADAM MIERZWA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2021–2024
$1,069.25
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $274.04 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Neurelis, Inc. | $107.13 | 3 |
| UCB, Inc. | $38.52 | 2 |
| SK Life Science, Inc. | $34.01 | 2 |
| Otsuka America Pharmaceutical, Inc. | $18.18 | 1 |
| Alexion Pharmaceuticals, Inc. | $16.74 | 1 |
| CSL Behring | $16.57 | 1 |
| ACADIA Pharmaceuticals Inc | $14.85 | 1 |
| ARGENX US, INC. | $14.54 | 1 |
| PFIZER INC. | $13.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $14.85 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147984378 | CMS |
| Alexion Pharmaceuticals, Inc. | $16.74 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093901372 | CMS |
| ARGENX US, INC. | $14.54 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142105533 | CMS |
| CSL Behring | $16.57 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134627989 | CMS |
| Neurelis, Inc. | $67.16 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145648296 | CMS |
| Neurelis, Inc. | $20.42 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145648298 | CMS |
| Neurelis, Inc. | $19.55 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145648300 | CMS |
| Otsuka America Pharmaceutical, Inc. | $18.18 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118942755 | CMS |
| PFIZER INC. | $13.50 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131289739 | CMS |
| SK Life Science, Inc. | $15.91 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154153049 | CMS |
| SK Life Science, Inc. | $18.10 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154153097 | CMS |
| UCB, Inc. | $25.22 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143349093 | CMS |
| UCB, Inc. | $13.30 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143349097 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.